Evaluation of Safety and Efficacy of Brimonidine Tartrate Ophthalmic Suspension

• Status: Completed
• Trial end date: 2020-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The study will be conducted to evaluate the efficacy and safety of topical administration of brimonidine tartrate ophthalmic suspension compared with brimonidine tartrate ophthalmic solution.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Sun Pharma Advanced Research Company Limited
• Treatments: Brimonidine Tartrate; Ophthalmic Solutions; Pharmaceutical Solutions

Criteria

Inclusion Criteria:

1. Be male or female, of 2 years of age or older

2. Have open-angle glaucoma or ocular hypertension in both the eyes

3. Be able and willing to follow study instructions and complete all required visits.

Exclusion Criteria:

1. Females who are pregnant/lactating.

2. Have uncontrolled systemic disease which might interfere with the study

3. Any known allergy or sensitivity to the study medications or their components

4. Any other clinically relevant abnormality